Amylin Pharmaceuticals, Inc.
9360 Towne Centre Drive
San Diego
California
92121
United States
Tel: 858-552-2200
Fax: 858-552-2212
Website: http://www.amylin.com/
Email: IR@amylin.com
370 articles about Amylin Pharmaceuticals, Inc.
-
Researchers continue to explore how to turn deadly venom into life-saving drugs. Several papers on the subject have recently been published and BioSpace is taking a look at them.
-
Movers and Shakers for Sept. 10
9/10/2018
Let's take a look at who made a splash in the pharma and biotech world the past week. -
ViaCyte, Inc. (Formerly Known as Novocell, Inc.) Appoints Mark Foletta, Former CFO Of Amylin Pharmaceuticals, Inc., To Its Board Of Directors
12/18/2013
-
Bristol-Myers Squibb Company Closing Amylin Pharmaceuticals, Inc.'s San Diego Operations, Cutting Hundreds of Employees
4/5/2013
-
BioMed Realty Trust Appoints Former Amylin Pharmaceuticals, Inc. President and Chief Executive Officer to its Board of Directors
1/4/2013
-
BioMed Realty Trust Appoints Former Amylin Pharmaceuticals, Inc. President and CEO to Its Board of Directors
1/4/2013
-
Takeda Pharmaceuticals, Amylin Pharmaceuticals, Inc. Terminate $1 Billion Anti-Obesity Pact
1/1/2013
-
Amylin Pharmaceuticals, Inc. Launches This Week I Will Pledge Campaign to Encourage Adults with Type 2 Diabetes to Set Weekly Goals While Giving Back to Diabetes Community
9/27/2012
-
Eli Lilly and Company Rakes in $790 Million From Amylin Pharmaceuticals, Inc.
8/10/2012
-
AstraZeneca PLC Pays $135 Million to Buy Equal Say Over Amylin Pharmaceuticals, Inc. Drugs
8/9/2012
-
Bristol-Myers Squibb Company Announces Successful Completion of Cash Tender Offer for Shares of Amylin Pharmaceuticals, Inc.
8/8/2012
-
Bristol-Myers Squibb Company Announces Expiration of the Hart-Scott-Rodino Waiting Period for Acquisition of Amylin Pharmaceuticals, Inc.
8/1/2012
-
Bristol-Myers Squibb Company ’s Second Quarter Highlighted by the Planned Strategic Acquisition of Amylin Pharmaceuticals, Inc. and Important Clinical Data in Immuno-Oncology
7/25/2012
-
Bristol-Myers Squibb Company Begins Tender Offer to Acquire Amylin Pharmaceuticals, Inc.
7/10/2012
-
AstraZeneca PLC, Bristol-Myers Squibb Company Join Forces in $7 Billion Deal for Amylin Pharmaceuticals, Inc.
7/3/2012
-
FDA: Amylin Pharmaceuticals, Inc. Concealed Heart Safety Risks of Key Diabetes Drug
6/27/2012
-
Amylin Pharmaceuticals, Inc. Release: New Clinical Data Analyses Show Metreleptin Reduced Blood Glucose and Triglyceride Levels in Patients With Rare Forms of Lipodystrophy
6/26/2012
-
Novo Nordisk A/S Says Victoza Superior to Amylin Pharmaceuticals, Inc. Rival
6/12/2012
-
Amylin Pharmaceuticals, Inc. Release: SYMLIN® Use Helped Patients With Type 2 or Type 1 Diabetes Achieve More Time in Normal Glucose Range
6/11/2012
-
Amylin Pharmaceuticals, Inc. Release: Once-Weekly BYDUREON™ Provided Greater Glucose Control, Weight Loss and Lower Risk of Hypoglycemia Compared to Once- or Twice-Daily Levemir® in Type 2 Diabetes
6/11/2012